These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 15546712
21. New artesunic acid homodimers: potent reversal agents of multidrug resistance in leukemia cells. Reiter C, Herrmann A, Çapci A, Efferth T, Tsogoeva SB. Bioorg Med Chem; 2012 Sep 15; 20(18):5637-41. PubMed ID: 22884578 [Abstract] [Full Text] [Related]
22. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer. Li Y, Zhang HB, Huang WL, Li YM. Bioorg Med Chem Lett; 2008 Jun 15; 18(12):3652-5. PubMed ID: 18502125 [Abstract] [Full Text] [Related]
23. Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity. Kawase M, Sakagami H, Motohashi N, Hauer H, Chatterjee SS, Spengler G, Vigyikanne AV, Molnár A, Molnár J. In Vivo; 2005 Jun 15; 19(4):705-11. PubMed ID: 15999537 [Abstract] [Full Text] [Related]
24. Design, synthesis, and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range. Teodori E, Dei S, Quidu P, Budriesi R, Chiarini A, Garnier-Suillerot A, Gualtieri F, Manetti D, Romanelli MN, Scapecchi S. J Med Chem; 1999 May 20; 42(10):1687-97. PubMed ID: 10346921 [Abstract] [Full Text] [Related]
25. Discovery of 2-arylthiazolidine-4-carboxylic acid amides as a new class of cytotoxic agents for prostate cancer. Gududuru V, Hurh E, Dalton JT, Miller DD. J Med Chem; 2005 Apr 07; 48(7):2584-8. PubMed ID: 15801848 [Abstract] [Full Text] [Related]
26. Novel benzopyridothiadiazepines as potential active antitumor agents. Lebegue N, Gallet S, Flouquet N, Carato P, Pfeiffer B, Renard P, Léonce S, Pierré A, Chavatte P, Berthelot P. J Med Chem; 2005 Nov 17; 48(23):7363-73. PubMed ID: 16279796 [Abstract] [Full Text] [Related]
27. Synthesis and multidrug-resistance modulating activity of a series of thienothiazines. Chiba P, Erker T, Galanski M, Hitzler M, Ecker GF. Arch Pharm (Weinheim); 2002 May 17; 335(5):223-8. PubMed ID: 12210779 [Abstract] [Full Text] [Related]
28. Synthesis of 7-oxo-7H-naphtho[1,2,3-de]quinoline derivatives as potential anticancer agents active on multidrug resistant cell lines. Dzieduszycka M, Bontemps-Gracz MM, Stefańska B, Martelli S, Piwkowska A, Arciemiuk M, Borowski E. Bioorg Med Chem; 2006 May 01; 14(9):2880-6. PubMed ID: 16458007 [Abstract] [Full Text] [Related]
29. Benzo[b]-1,8-naphthyridine derivatives: synthesis and reversal activity on multidrug resistance. Misbahi H, Brouant P, Hevér A, Molnár AM, Wolfard K, Spengler G, Mefetah H, Molnár J, Barbe J. Anticancer Res; 2002 May 01; 22(4):2097-101. PubMed ID: 12174889 [Abstract] [Full Text] [Related]
30. Novel pyxinol amide derivatives bearing an aliphatic heterocycle as P-glycoprotein modulators for overcoming multidrug resistance. Yu L, Ren R, Li S, Zhang C, Chen C, Lv H, Zou Z, Pei X, Song Z, Zhang P, Wang H, Yang G. Eur J Med Chem; 2024 Jun 05; 272():116466. PubMed ID: 38704938 [Abstract] [Full Text] [Related]
31. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms. Li X, Li JP, Yuan HY, Gao X, Qu XJ, Xu WF, Tang W. Methods Find Exp Clin Pharmacol; 2007 Nov 05; 29(9):607-17. PubMed ID: 18193112 [Abstract] [Full Text] [Related]
32. Modification of marine natural product ningalin B and SAR study lead to potent P-glycoprotein inhibitors. Yang C, Wong IL, Jin WB, Jiang T, Chow LM, Wan SB. Mar Drugs; 2014 Oct 17; 12(10):5209-21. PubMed ID: 25329704 [Abstract] [Full Text] [Related]
33. Synthesis of curcumin mimics with multidrug resistance reversal activities. Um Y, Cho S, Woo HB, Kim YK, Kim H, Ham J, Kim SN, Ahn CM, Lee S. Bioorg Med Chem; 2008 Apr 01; 16(7):3608-15. PubMed ID: 18295490 [Abstract] [Full Text] [Related]
34. Papyriferic acid derivatives as reversal agents of multidrug resistance in cancer cells. Xiong J, Taniguchi M, Kashiwada Y, Sekiya M, Yamagishi T, Takaishi Y. Bioorg Med Chem; 2010 Apr 15; 18(8):2964-75. PubMed ID: 20363142 [Abstract] [Full Text] [Related]
35. Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines. Engi H, Sakagami H, Kawase M, Parecha A, Manvar D, Kothari H, Adlakha P, Shah A, Motohashi N, Ocsovszki I, Molnár J. In Vivo; 2006 Apr 15; 20(5):637-43. PubMed ID: 17091771 [Abstract] [Full Text] [Related]
36. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents. Xue N, Yang X, Wu R, Chen J, He Q, Yang B, Lu X, Hu Y. Bioorg Med Chem; 2008 Mar 01; 16(5):2550-7. PubMed ID: 18226907 [Abstract] [Full Text] [Related]
37. Design, synthesis, and biological evaluation of potent quinoline and pyrroloquinoline ammosamide analogues as inhibitors of quinone reductase 2. Reddy PV, Jensen KC, Mesecar AD, Fanwick PE, Cushman M. J Med Chem; 2012 Jan 12; 55(1):367-77. PubMed ID: 22206487 [Abstract] [Full Text] [Related]
38. Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines. Rocha Gda G, Simões M, Lúcio KA, Oliveira RR, Coelho Kaplan MA, Gattass CR. Bioorg Med Chem; 2007 Dec 01; 15(23):7355-60. PubMed ID: 17889544 [Abstract] [Full Text] [Related]
39. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents. Chang JY, Yang MF, Chang CY, Chen CM, Kuo CC, Liou JP. J Med Chem; 2006 Oct 19; 49(21):6412-5. PubMed ID: 17034147 [Abstract] [Full Text] [Related]